Magnet Bio is a company that appears to specialize in biotechnology solutions. The exact nature of their products or services is not specified in the provided context, but their involvement in the healthcare sector is implied by their name and privacy policy page.

Magnet Bio

Magnet Biomedicine is a biotechnology company advancing molecular glue discovery with rational selection and design. We are reimagining what is achievable with molecular glues by looking beyond known protein–protein interactions and analyzing the broad protein landscape to pair target proteins with rationally selected presenter proteins to drive therapeutic effects. Our TrueGlue™ discovery platform applies cutting-edge advancements in human biology and proteomics to identify fit-for-purpose glues that offer category-leading benefits and maximize therapeutic impact.

Magnet Biomedicine

🔬 Exciting News from Magnet Biomedicine! 🌟 
 
👥 We're thrilled to announce that our leadership team will be attending the JP Morgan Healthcare Conference 2024! Our President & Chief Scientific Officer,  Brian Safina, Ph.D., along with Bret Williams, Ph.D., Vice President of Biology, and Diala Ezzeddine, Ph.D. from our corporate development team will be in attendance.    
 
Here's a sneak peek:

🤝 Strategic Partnerships & Relationships: At JP Morgan Healthcare Conference 2024, we're eager to explore new collaborations with established pharma players. Our focus is on building strong, mutually beneficial partnerships that can leverage our TrueGlue™ Discovery platform for groundbreaking advancements in precision medicine. 
 
🧬 Pipeline Progress: Witness the evolution of our TrueGlue™ Discovery platform, a testament to our commitment to innovation. We're excited to discuss how our platform is opening doors to new therapeutic possibilities, especially in addressing previously untreatable conditions. 
 
Join us in shaping the future of molecular glues in healthcare. The journey continues! 
 
Interested in connecting with us at the conference or via LinkedIn? Reach out to Diala Ezzeddine dezzeddine@magnetbio.com or visit our website at magnetbio.com.  
 
Let's innovate together! 
 
#JPM2024 #MagnetBiomedicine #HealthcareInnovation  

 

A new domain for the next chapter of our journey:  This week our team gathered to celebrate our new lab + office space in South End, Boston!

#Biotech #MolecularGlues

We had a great time chatting with Ryan Cross and Endpoints News about our Series A and the vast potential of molecular glues to address cancer, cardiovascular disease, immune disorders, and beyond 🧲

Check out the full article: https://lnkd.in/ejmS_Tqa


Thank you to our team and scientific founders, molecular glue pioneer Stuart Schreiber, 2017 Nobel Laureate Michael Rosbash, chemoproteomics pioneer Benjamin Cravatt, human geneticist Richa Saxena, and chemical biologist David Spiegel, for your commitment to advancing pioneering science with the potential to unlock new therapeutics.

#TrueGlues #MolecularGlues #Chemoproteomics #Biotech

Our TrueGlue™ discovery platform leverages next-generation technologies to identify TrueGlues, small molecules that offer category-leading benefits and opportunities to bring novel treatment options to patients.

Visit our website to learn more: magnetbio.com

#MolecularGlues #Biotech #DrugDiscovery

Today, Magnet Bio emerges from stealth with $50M in Series A financing. We’re building on the work of our scientific founders, advancing molecular glue discovery with rational selection and design to bring novel medicines to patients across a vast range of indications.     

Learn more at: https://magnetbio.com/

#MolecularGlues #Biotech #Startup

Metric
Company Name	Magnet Bio
Symbol
MSH ID	COM:MAGNETBIO
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	US
Stage
Employee Count	32
Website	magnetbio.com
LinkedIn	magnet-biomedicine
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	44.89
28-Day Growth Score	9.95
90-Day Growth Score	20.17
365-Day Growth Score	19.52

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:MAGNETBIO

Magnet Bio

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue